Effect of thromboxane A2-synthetase inhibitor OKY-046 and evening primrose oil (Efamol) on mercuric chloride induced autoimmune glomerulonephritis in Brown-Norway rats.
Papanikolaou
N
N
Pathologie Rénale et Vasculaire, INSERM U.28, Hôpital, Broussais, Paris, France.
Hatziantoniou
C
C
Gkika
E L
EL
D000179:Acrylates / Q000627:therapeutic use*; D000818:Animals; D005228:Fatty Acids, Essential / Q000627:therapeutic use*; D005260:Female; D005922:Glomerulonephritis, IGA / Q000139:chemically induced / Q000188:drug therapy* / Q000652:urine; D008041:Linoleic Acids; D008627:Mercuric Chloride; D008689:Methacrylates / Q000627:therapeutic use*; D031665:Oenothera biennis; D010938:Plant Oils; D011453:Prostaglandins / Q000652:urine; D011507:Proteinuria; D051381:Rats; D011914:Rats, Inbred BN; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D017965:gamma-Linolenic Acid
D000179:Acrylates; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D008689:Methacrylates; D010938:Plant Oils; D011453:Prostaglandins; C028498:evening primrose oil; D008627:Mercuric Chloride; D017965:gamma-Linolenic Acid; D013930:Thromboxane-A Synthase; C034364:ozagrel